Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.
Inhibiting the growth of tumor vasculature represents one of the relevant strategies against tumor progression. Between all the different pro-angiogenic molecular targets, plasma membrane glycosphingolipids have been under-investigated. In this present study, we explore the anti-angiogenic therapeut...
Guardado en:
Autores principales: | Ariane Desselle, Tanguy Chaumette, Marie-Hélène Gaugler, Denis Cochonneau, Julien Fleurence, Nolwenn Dubois, Philippe Hulin, Jacques Aubry, Stéphane Birklé, François Paris |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/744a37d030464bac94fddfaa1b125e3b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.
por: Nidia Alvarez-Rueda, et al.
Publicado: (2011) -
Modulation of Epstein-Barr Virus Glycoprotein B (gB) Fusion Activity by the gB Cytoplasmic Tail Domain
por: Nicholas J. Garcia, et al.
Publicado: (2013) -
Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation.
por: Dale Christiansen, et al.
Publicado: (2008) -
The functions of еру modal verb «should» in the corpus ice-gb
por: R. Y. Abbasov
Publicado: (2014) - Monoclonal antibodies in immunodiagnosis and immunotherapy